Sonde is a leader in voice-based health monitoring. Sonde serves top health companies, providers, pharma, and device OEMs through its vocal biomarker platform. Leveraging a best-in-class voice data set with over 1.2 million samples from 85,000+ individuals on 4 continents, Sonde uses advanced audio signal processing, speech science, and AI/machine learning to sense and analyze subtle vocal changes due to changes in a person's physiology to provide key insights into health and well-being.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/09/22 | $19,250,000 | Series B |
KT Corporation M Ventures NEOM Company Partners Investment Co.  PureTech Health | undisclosed |
